300584 海辰药业
已收盘 06-09 15:00:00
资讯
新帖
简况
海辰药业(300584.SZ)：注射用盐酸头孢甲肟通过仿制药一致性评价
智通财经 · 06-05
海辰药业(300584.SZ)：注射用盐酸头孢甲肟通过仿制药一致性评价
股市必读：海辰药业（300584）今年截至6月2日累计跌幅已超30%
证券之星 · 06-03
股市必读：海辰药业（300584）今年截至6月2日累计跌幅已超30%
海辰药业（300584）披露2025年度股东会决议公告，5月28日股价下跌0.4%
证券之星 · 05-28
海辰药业（300584）披露2025年度股东会决议公告，5月28日股价下跌0.4%
股市必读：海辰药业（300584）今年截至5月21日累计跌幅已超25%
证券之星 · 05-22
股市必读：海辰药业（300584）今年截至5月21日累计跌幅已超25%
5月21日海辰药业创60日新低，博时战略新材料主题混合A基金重仓该股
证券之星 · 05-21
5月21日海辰药业创60日新低，博时战略新材料主题混合A基金重仓该股
5月12日海辰药业跌5.04%，博时战略新材料主题混合A基金重仓该股
证券之星 · 05-12
5月12日海辰药业跌5.04%，博时战略新材料主题混合A基金重仓该股
4月29日海辰药业涨5.92%，博时战略新材料主题混合A基金重仓该股
证券之星 · 04-29
4月29日海辰药业涨5.92%，博时战略新材料主题混合A基金重仓该股
股市必读：海辰药业年报 - 第四季度单季净利润同比下降22.49%
证券之星 · 04-27
股市必读：海辰药业年报 - 第四季度单季净利润同比下降22.49%
海辰药业（300584）2026年一季报简析：营收净利润同比双双增长
证券之星 · 04-26
海辰药业（300584）2026年一季报简析：营收净利润同比双双增长
图解海辰药业年报：第四季度单季净利润同比下降22.49%
证券之星 · 04-25
图解海辰药业年报：第四季度单季净利润同比下降22.49%
海辰药业：截至4月10日，公司股东数为22503户
证券之星 · 04-15
海辰药业：截至4月10日，公司股东数为22503户
海辰药业：截至3月31日，公司股东数为22802户
证券之星 · 04-08
海辰药业：截至3月31日，公司股东数为22802户
4月1日海辰药业涨6.13%，中信建投低碳成长混合A基金重仓该股
证券之星 · 04-01
4月1日海辰药业涨6.13%，中信建投低碳成长混合A基金重仓该股
3月27日海辰药业涨11.17%，中信建投低碳成长混合A基金重仓该股
证券之星 · 03-27
3月27日海辰药业涨11.17%，中信建投低碳成长混合A基金重仓该股
海辰药业：截至3月20日收盘，公司股东户数为20330户
证券之星 · 03-25
海辰药业：截至3月20日收盘，公司股东户数为20330户
股市必读：海辰药业（300584）今年截至3月23日累计跌幅已超20%
证券之星 · 03-24
股市必读：海辰药业（300584）今年截至3月23日累计跌幅已超20%
3月20日海辰药业创60日新低，中信建投低碳成长混合A基金重仓该股
证券之星 · 03-20
3月20日海辰药业创60日新低，中信建投低碳成长混合A基金重仓该股
3月13日海辰药业涨5.13%，中信建投低碳成长混合A基金重仓该股
证券之星 · 03-13
3月13日海辰药业涨5.13%，中信建投低碳成长混合A基金重仓该股
海辰药业(300584)2月13日股东户数2.11万户，较上期减少0.07%
证券之星 · 02-26
海辰药业(300584)2月13日股东户数2.11万户，较上期减少0.07%
海辰药业：截至1月30日收盘，公司股东户数为21,149户
证券之星 · 02-03
海辰药业：截至1月30日收盘，公司股东户数为21,149户
公司概况
公司名称：
南京海辰药业股份有限公司
所属行业：
医药制造业
上市日期：
2017-01-12
主营业务：
南京海辰药业股份有限公司的主营业务是化学制剂、原料药及中间体的研发、生产、销售，同时拓展锂电材料业务。公司的主要产品是抗生素类、抗病毒类、利尿类、消化类、免疫调节类、心脑血管类、原料药及中间体、锂电池电解液添加剂。
发行价格：
11.11
{"stockData":{"symbol":"300584","market":"SZ","secType":"STK","nameCN":"海辰药业","latestPrice":31.52,"timestamp":1780988586000,"preClose":31.19,"halted":0,"volume":1920300,"delay":0,"changeRate":0.0106,"floatShares":82131500,"shares":120000000,"eps":0.3699,"marketStatus":"已收盘","change":0.33,"latestTime":"06-09 15:00:00","open":31.86,"high":31.86,"low":30.76,"amount":60142600,"amplitude":0.0353,"askPrice":31.52,"askSize":9,"bidPrice":31.51,"bidSize":134,"shortable":0,"etf":0,"ttmEps":0.3699,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1781055000000},"marketStatusCode":5,"adr":0,"adjPreClose":31.19,"symbolType":"stock","openAndCloseTimeList":[[1780968600000,1780975800000],[1780981200000,1780988400000]],"highLimit":34.31,"lowLimit":28.07,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":120000000,"isCdr":false,"pbRate":3.5,"roa":"--","peRate":85.21222,"roe":"1.64%","epsLYR":0.3505,"committee":0.442815,"marketValue":3782000000,"turnoverRate":0.0234,"status":0,"floatMarketCap":2589000000},"requestUrl":"/m/hq/s/300584/wiki","defaultTab":"wiki","newsList":[{"id":"2641180113","title":"海辰药业(300584.SZ)：注射用盐酸头孢甲肟通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2641180113","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641180113?lang=zh_cn&edition=full","pubTime":"2026-06-05 15:54","pubTimestamp":1780646071,"startTime":"0","endTime":"0","summary":"智通财经APP讯，海辰药业(300584.SZ)发布公告，公司于近日收到国家药品监督管理局核准签发的《药品补充申请批准通知书》，该产品通过仿制药质量和疗效一致性评价。注射用盐酸头孢甲肟是第三代头孢菌素类药物，通过抑制细胞壁的生物合成而产生杀菌作用，对革兰阴性菌、阳性菌均有良好的抗菌作用，是一种临床应用广泛的广谱抗生素，具有广谱、耐酶、高效、安全的特性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1450662.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"海辰药业(300584.SZ)：注射用盐酸头孢甲肟通过仿制药一致性评价","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","300584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640947293","title":"股市必读：海辰药业（300584）今年截至6月2日累计跌幅已超30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640947293","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640947293?lang=zh_cn&edition=full","pubTime":"2026-06-03 01:44","pubTimestamp":1780422256,"startTime":"0","endTime":"0","summary":"截至2026年6月2日收盘，海辰药业报收于33.39元，下跌3.39%，换手率4.14%，成交量3.4万手，成交额1.14亿元。交易信息汇总股价提醒6月2日海辰药业收盘报33.39元，跌3.39%，当日成交1.14亿元。根据收盘数据统计，该股当年累计跌幅30.83%。前10个交易日资金流向情况：主力资金累计净流出6017.16万元，股价累计下跌19.46%资金流向6月2日主力资金净流出1465.82万元；游资资金净流入70.65万元；散户资金净流入1395.17万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300001915.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638661346","title":"海辰药业（300584）披露2025年度股东会决议公告，5月28日股价下跌0.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638661346","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638661346?lang=zh_cn&edition=full","pubTime":"2026-05-28 17:34","pubTimestamp":1779960867,"startTime":"0","endTime":"0","summary":"截至2026年5月28日收盘，海辰药业报收于34.43元，较前一交易日下跌0.4%，最新总市值为41.32亿元。该股当日开盘34.35元，最高34.7元，最低33.68元，成交额达9347.66万元，换手率为3.32%。近日，南京海辰药业股份有限公司发布《2025年度股东会决议公告》。出席会议股东代表股份占公司总股份的52.4633%，各项议案均获有效表决权过半数通过。江苏世纪同仁律师事务所对本次会议出具法律意见书，认为会议召集、召开及表决程序合法有效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052800031572.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637135923","title":"股市必读：海辰药业（300584）今年截至5月21日累计跌幅已超25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637135923","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637135923?lang=zh_cn&edition=full","pubTime":"2026-05-22 03:22","pubTimestamp":1779391357,"startTime":"0","endTime":"0","summary":"截至2026年5月21日收盘，海辰药业报收于36.6元，下跌3.84%，换手率2.99%，成交量2.46万手，成交额9273.96万元。当日关注点来自交易信息汇总：海辰药业5月21日收盘价36.6元，跌3.84%，当日成交245.6万元，年内累计跌幅达25.09%。来自资金流向：主力资金连续10个交易日净流出，累计达1.06亿元，同期股价下跌8.56%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200004909.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637386369","title":"5月21日海辰药业创60日新低，博时战略新材料主题混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2637386369","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637386369?lang=zh_cn&edition=full","pubTime":"2026-05-21 16:49","pubTimestamp":1779353373,"startTime":"0","endTime":"0","summary":"证券之星消息，5月21日海辰药业创60日新低，收盘报36.6元，当日跌3.84%，换手率2.99%，成交量2.46万手，成交额9273.96万元。重仓海辰药业的公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为博时基金的博时战略新材料主题混合A。博时战略新材料主题混合A目前规模为0.37亿元，最新净值1.15，较上一交易日上涨2.84%，近一年上涨33.01%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100030911.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584","159703","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634299886","title":"5月12日海辰药业跌5.04%，博时战略新材料主题混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2634299886","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634299886?lang=zh_cn&edition=full","pubTime":"2026-05-12 16:30","pubTimestamp":1778574655,"startTime":"0","endTime":"0","summary":"证券之星消息，5月12日海辰药业跌5.04%，收盘报40.55元，换手率7.0%，成交量5.75万手，成交额2.36亿元。重仓海辰药业的公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为博时基金的博时战略新材料主题混合A。博时战略新材料主题混合A目前规模为0.37亿元，最新净值1.1674，较上一交易日上涨0.87%，近一年上涨36.31%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051200027299.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584","159703"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631560919","title":"4月29日海辰药业涨5.92%，博时战略新材料主题混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2631560919","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631560919?lang=zh_cn&edition=full","pubTime":"2026-04-29 16:38","pubTimestamp":1777451916,"startTime":"0","endTime":"0","summary":"证券之星消息，4月29日海辰药业涨5.92%，收盘报43.32元，换手率9.11%，成交量7.48万手，成交额3.23亿元。重仓海辰药业的公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为博时基金的博时战略新材料主题混合A。博时战略新材料主题混合A目前规模为0.37亿元，最新净值1.0683，较上一交易日下跌3.43%，近一年上涨28.73%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900052334.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","159703","300584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630334125","title":"股市必读：海辰药业年报 - 第四季度单季净利润同比下降22.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630334125","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630334125?lang=zh_cn&edition=full","pubTime":"2026-04-27 07:18","pubTimestamp":1777245492,"startTime":"0","endTime":"0","summary":"股本股东变化股东户数变动近日海辰药业披露，截至2026年4月10日公司股东户数为2.25万户，较3月31日减少299.0户，减幅为1.31%。2026年一季度报告海辰药业2026年第一季度报告显示，报告期内公司实现营业收入160,335,652.32元，同比增长12.40%；归属于上市公司股东的净利润为17,362,971.70元，同比增长15.47%；扣除非经常性损益后的净利润为17,515,079.32元，同比增长16.75%。经营活动产生的现金流量净额为10,614,521.06元，同比下降75.41%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700007020.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630077558","title":"海辰药业（300584）2026年一季报简析：营收净利润同比双双增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2630077558","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630077558?lang=zh_cn&edition=full","pubTime":"2026-04-26 06:27","pubTimestamp":1777156078,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期海辰药业发布2026年一季报。根据财报显示，海辰药业营收净利润同比双双增长。截至本报告期末，公司营业总收入1.6亿元，同比上升12.4%，归母净利润1736.3万元，同比上升15.47%。本次财报公布的各项数据指标表现尚佳。去年的净利率为6.07%，算上全部成本后，公司产品或服务的附加值一般。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600003752.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630209829","title":"图解海辰药业年报：第四季度单季净利润同比下降22.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630209829","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630209829?lang=zh_cn&edition=full","pubTime":"2026-04-25 01:20","pubTimestamp":1777051232,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业2025年年报显示，当年度公司主营收入6.71亿元，同比上升33.05%；归母净利润4205.84万元，同比上升4.58%；扣非净利润6027.67万元，同比上升48.4%；其中2025年第四季度，公司单季度主营收入2.0亿元，同比上升38.69%；单季度归母净利润937.99万元，同比下降22.49%；单季度扣非净利润3073.36万元，同比上升166.06%；负债率28.21%，投资收益-359.27万元，财务费用662.0万元，毛利率82.51%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042500003959.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627472922","title":"海辰药业：截至4月10日，公司股东数为22503户","url":"https://stock-news.laohu8.com/highlight/detail?id=2627472922","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627472922?lang=zh_cn&edition=full","pubTime":"2026-04-15 11:36","pubTimestamp":1776224207,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业(300584)04月15日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问截止4月10日公司股东人数是多少，谢谢。海辰药业回复：尊敬的投资者您好，截至4月10日，公司股东数为22503户，感谢对海辰药业的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041500019076.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625999486","title":"海辰药业：截至3月31日，公司股东数为22802户","url":"https://stock-news.laohu8.com/highlight/detail?id=2625999486","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625999486?lang=zh_cn&edition=full","pubTime":"2026-04-08 11:31","pubTimestamp":1775619062,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业(300584)04月08日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截至2026年3月31日，公司最新股东数是多少？海辰药业回复：尊敬的投资者您好，截至3月31日，公司股东数为22802户，感谢对海辰药业的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040800014052.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624595875","title":"4月1日海辰药业涨6.13%，中信建投低碳成长混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2624595875","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624595875?lang=zh_cn&edition=full","pubTime":"2026-04-01 16:17","pubTimestamp":1775031464,"startTime":"0","endTime":"0","summary":"证券之星消息，4月1日海辰药业涨6.13%，收盘报46.78元，换手率14.27%，成交量11.71万手，成交额5.43亿元。重仓海辰药业的公募基金请见下表：根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共4家，其中持有数量最多的公募基金为中信建投基金的中信建投低碳成长混合A。中信建投低碳成长混合A目前规模为1.86亿元，最新净值0.5194，较上一交易日下跌3.06%，近一年上涨14.38%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040100029137.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0276","300584","601066","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622284980","title":"3月27日海辰药业涨11.17%，中信建投低碳成长混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2622284980","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622284980?lang=zh_cn&edition=full","pubTime":"2026-03-27 16:17","pubTimestamp":1774599445,"startTime":"0","endTime":"0","summary":"证券之星消息，3月27日海辰药业涨11.17%，收盘报45.18元，换手率15.94%，成交量13.09万手，成交额5.8亿元。重仓海辰药业的公募基金请见下表：根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共4家，其中持有数量最多的公募基金为中信建投基金的中信建投低碳成长混合A。中信建投低碳成长混合A目前规模为1.86亿元，最新净值0.5253，较上一交易日下跌0.61%，近一年上涨8.53%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032700033470.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584","601066","BK0276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622461660","title":"海辰药业：截至3月20日收盘，公司股东户数为20330户","url":"https://stock-news.laohu8.com/highlight/detail?id=2622461660","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622461660?lang=zh_cn&edition=full","pubTime":"2026-03-25 11:36","pubTimestamp":1774409770,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业(300584)03月24日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止3月20日公司股东人数是多少？谢谢！海辰药业回复：尊敬的投资者您好，截至3月20日收盘，公司股东户数为20330户，感谢对海辰药业的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032500019546.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621085820","title":"股市必读：海辰药业（300584）今年截至3月23日累计跌幅已超20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621085820","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621085820?lang=zh_cn&edition=full","pubTime":"2026-03-24 01:49","pubTimestamp":1774288150,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘，海辰药业报收于38.11元，下跌5.67%，换手率4.36%，成交量3.58万手，成交额1.39亿元。来自交易信息汇总：3月23日散户资金净流入1400.74万元，与主力资金形成明显反向流动。交易信息汇总3月23日海辰药业收盘报38.11元，跌5.67%，当日成交358.12万元。该股已连续5日下跌，当年累计跌幅23.63%。前10个交易日主力资金累计净流出2338.22万元，股价累计下跌8.97%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400001728.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620786116","title":"3月20日海辰药业创60日新低，中信建投低碳成长混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2620786116","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620786116?lang=zh_cn&edition=full","pubTime":"2026-03-20 16:27","pubTimestamp":1773995226,"startTime":"0","endTime":"0","summary":"证券之星消息，3月20日海辰药业创60日新低，收盘报40.4元，当日跌2.37%，换手率4.15%，成交量3.41万手，成交额1.4亿元。重仓海辰药业的公募基金请见下表：根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共4家，其中持有数量最多的公募基金为中信建投基金的中信建投低碳成长混合A。中信建投低碳成长混合A目前规模为1.86亿元，最新净值0.5378，较上一交易日下跌2.57%，近一年上涨10.57%。该公募基金现任基金经理为周紫光。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032000027989.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0276","601066","300584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619316294","title":"3月13日海辰药业涨5.13%，中信建投低碳成长混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2619316294","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619316294?lang=zh_cn&edition=full","pubTime":"2026-03-13 16:26","pubTimestamp":1773390411,"startTime":"0","endTime":"0","summary":"证券之星消息，3月13日海辰药业涨5.13%，收盘报44.85元，换手率10.33%，成交量8.48万手，成交额3.8亿元。重仓海辰药业的公募基金请见下表：根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共4家，其中持有数量最多的公募基金为中信建投基金的中信建投低碳成长混合A。中信建投低碳成长混合A目前规模为1.86亿元，最新净值0.5774，较上一交易日下跌1.08%，近一年上涨18.73%。该公募基金现任基金经理为周紫光。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031300027331.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0276","BK0239","300584","601066"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614162810","title":"海辰药业(300584)2月13日股东户数2.11万户，较上期减少0.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614162810","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614162810?lang=zh_cn&edition=full","pubTime":"2026-02-26 17:18","pubTimestamp":1772097510,"startTime":"0","endTime":"0","summary":"证券之星消息，近日海辰药业披露，截至2026年2月13日公司股东户数为2.11万户，较1月30日减少14.0户，减幅为0.07%。在化学制药行业个股中，海辰药业股东户数低于行业平均水平，截至2月13日，化学制药行业平均股东户数为3.43万户。从股价来看，2026年1月30日至2026年2月13日，海辰药业区间跌幅为2.96%，在此期间股东户数减少14.0户，减幅为0.07%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022600026158.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608843949","title":"海辰药业：截至1月30日收盘，公司股东户数为21,149户","url":"https://stock-news.laohu8.com/highlight/detail?id=2608843949","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608843949?lang=zh_cn&edition=full","pubTime":"2026-02-03 11:33","pubTimestamp":1770089602,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业(300584)02月02日在投资者关系平台上答复投资者关心的问题。投资者提问：你好，公司截止1月30日最新的股东人数是多少？海辰药业回复：尊敬的投资者您好，截至1月30日收盘，公司股东户数为21,149户，感谢对海辰药业的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300016053.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1781044983636,"stockEarnings":[{"period":"1week","weight":-0.056},{"period":"1month","weight":-0.2566},{"period":"3month","weight":-0.2787},{"period":"6month","weight":-0.3722},{"period":"1year","weight":-0.2323},{"period":"ytd","weight":-0.3724}],"compareEarnings":[{"period":"1week","weight":-0.016},{"period":"1month","weight":-0.0407},{"period":"3month","weight":-0.0299},{"period":"6month","weight":0.0353},{"period":"1year","weight":0.1795},{"period":"ytd","weight":0.0104}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"南京海辰药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"20477人(较上一季度减少9.00%)","perCapita":"4010股","listingDate":"2017-01-12","address":"江苏省南京市栖霞区经济技术开发区恒发路1号","registeredCapital":"12000万元","survey":" 南京海辰药业股份有限公司的主营业务是化学制剂、原料药及中间体的研发、生产、销售，同时拓展锂电材料业务。公司的主要产品是抗生素类、抗病毒类、利尿类、消化类、免疫调节类、心脑血管类、原料药及中间体、锂电池电解液添加剂。","listedPrice":11.11},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海辰药业(300584)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海辰药业(300584)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海辰药业,300584,海辰药业股票,海辰药业股票老虎,海辰药业股票老虎国际,海辰药业行情,海辰药业股票行情,海辰药业股价,海辰药业股市,海辰药业股票价格,海辰药业股票交易,海辰药业股票购买,海辰药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海辰药业(300584)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海辰药业(300584)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}